Lightstone VC

What is Lightstone VC?

Lightstone Ventures is an investment firm focused on backing visionary founders in the biotech and medtech sectors. Founded in 2012, their mission is to fund novel, disruptive technologies that can transform patients' lives.

They operate with a thesis-driven investment strategy, prioritizing understanding of key market sectors and seeking out disruptive technologies while building robust relationships with key thought leaders. With a global presence through offices in the U.S. and Ireland, they leverage a worldwide network for strategic and financial funding sources as well as novel development and commercialization strategies.

Their portfolio reflects their commitment to building companies that aim to accomplish big goals and present impactful treatments to patients. With nearly 100 years of collective operational experience, the Lightstone team has a history of being a part of significant venture-backed life science exits including Alx Oncology, Nimbus, and Ardian among others.

They focus on first-in-class drugs across modalities like small molecules, biologics, and cell and gene therapies in various disease areas such as CNS, immunology, oncology, and ophthalmology.

In medtech, they target the convergence of technology, medicine, and consumer health, looking for personalized medicine approaches and groundbreaking medical technologies tailored for major diseases. They are not just investors but act as partners, collaborators, and mentors, engaging hands-on with founders to articulate strategies that transform visions into viable products.

Lightstone Ventures operates on the principle that the success of a company is determined by its people, hence they closely work with biotech and medtech founders to build experienced and ambitious teams aiming to achieve significant industry goals.